Affiliation: Ghent University
- The anti-tumoral activity of neoadjuvant intra-arterial 131I-lipiodol treatment for hepatocellular carcinoma: a pilot studyB Brans
Division of Nuclear Medicine, Ghent University Hospital, De Pintelaan 185, B 9000 Ghent, Belgium
Cancer Biother Radiopharm 16:333-8. 2001..This study was set up to investigate the anti-tumoral potential of neo-adjuvant 131I-lipiodol administration before liver transplantation...
- Recombinant humane thyrotropin (rhtSH) a new aid in the diagnosis and treatment of thyroid carcinoma with radio-iodineB Brans
Afdelingen Nucleaire Geneeskunde, Universitair Ziekenhuis Gent, Belgie
Acta Clin Belg 56:316-20. 2001..The role of rhTSH in the follow-up diagnosis and radioiodine treatment of thyroid carcinoma will undoubtedly increase in importance...
- Thyroidal uptake and radiation dose after repetitive I-131-MIBG treatments: influence of potassium iodide for thyroid blockingBoudewija Brans
Division of Nuclear Medicine, Ghent University Hospital, Belgium
Med Pediatr Oncol 38:41-6. 2002..Hypothyroidism might result from the undesirable irradiation of the thyroid gland. To prevent this, stable iodide such as potassium iodide (KI) is given to oversaturate the thyroid before I-131-MIBG is administered...
- Combining iodine-131 Lipiodol therapy with low-dose cisplatin as a radiosensitiser: preliminary results in hepatocellular carcinomaB Brans
Department of Nuclear Medicine, Ghent University Hospital, De Pintelaan 185, Belgium
Eur J Nucl Med Mol Imaging 29:928-32. 2002..Larger patient groups are necessary for confirmation and to establish the future role of (131)I-Lipiodol in hepatocellular carcinoma...